Literature DB >> 5957148

Unusual presentation of benign intracranial hypertension. Early treatment with oral glycerol.

M J Absolon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5957148      PMCID: PMC506305          DOI: 10.1136/bjo.50.12.683

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  11 in total

1.  EFFECT OF GLYCEROL BY MOUTH ON RAISED INTRACRANIAL PRESSURE IN MAN.

Authors:  M BUCKELL; L WALSH
Journal:  Lancet       Date:  1964-11-28       Impact factor: 79.321

2.  Benign forms of intracranial hypertension; toxic and otitic hydrocephalus.

Authors:  J FOLEY
Journal:  Brain       Date:  1955       Impact factor: 13.501

3.  Benign intracranial hypertension.

Authors:  E TURNER
Journal:  Trans Ophthalmol Soc U K       Date:  1961

4.  Late relapse of congenital ocular toxoplasmosis.

Authors:  J FRANCOIS
Journal:  Trans Ophthalmol Soc U K       Date:  1961

5.  Toxoplasmosis, a general introduction.

Authors:  C P BEATTIE
Journal:  Trans Ophthalmol Soc U K       Date:  1958

6.  A clinical correlation between encephalopathy and papilloedema in Addison's disease.

Authors:  A JEFFERSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1956-02       Impact factor: 10.154

7.  Benign intracranial hypertension.

Authors:  P BRADSHAW
Journal:  J Neurol Neurosurg Psychiatry       Date:  1956-02       Impact factor: 10.154

8.  Papilledema as the outstanding sign in meningeal hydrops.

Authors:  H GILLER; D G COGAN
Journal:  AMA Arch Ophthalmol       Date:  1952-11

9.  INTRACRANIAL PRESSURE WITHOUT BRAIN TUMOR: DIAGNOSIS AND TREATMENT.

Authors:  W E Dandy
Journal:  Ann Surg       Date:  1937-10       Impact factor: 12.969

10.  Thrombosis of the dural venous sinuses as a cause of pseudotumor cerebri.

Authors:  B S RAY; H S DUNBAR
Journal:  Ann Surg       Date:  1951-09       Impact factor: 12.969

View more
  1 in total

1.  Idiopathic Intracranial Hypertension.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.